يعرض 1 - 17 نتائج من 17 نتيجة بحث عن '"T. N. Galyan"', وقت الاستعلام: 0.55s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
    Academic Journal
  6. 6
    Academic Journal

    المصدر: Medical Visualization; Том 26, № 2 (2022); 81-90 ; Медицинская визуализация; Том 26, № 2 (2022); 81-90 ; 2408-9516 ; 1607-0763

    وصف الملف: application/pdf

    Relation: https://medvis.vidar.ru/jour/article/view/1149/724; https://medvis.vidar.ru/jour/article/downloadSuppFile/1149/1585; https://medvis.vidar.ru/jour/article/downloadSuppFile/1149/1586; Врожденный клапанный стеноз аорты (КСА): Клинические рекомендации МЗ РФ, 2016.; Iung B., Baron G., Butchart E.G. et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur. Heart J. 2003; 24 (13): 1231–1243. http://doi.org/10.1016/s0195-668x(03)00201-x; Myung, K. Park Aortic stenosis. In: Myung K. Park, MD // Pediatric Cardiology for Practitiones, 2008: 248–257. ISBN-13: 978-0323014441; ISBN-10: 0323014445; Иванов В.А., Евсеев Е.П., Айдамиров Я.А. Результаты протезирования при стенозе аортального клапана у пациентов со сниженной сократительной способностью миокарда левого желудочка. Кардиология и сердечно-сосудистая хирургия. 2016; 9 (5): 52–57. https://doi.org/10.17116/kardio20169552-57; Clift P.F., Cervi E. A review of thoracic aortic aneurysm disease.Echo Res. Pract. 2019; 7 (1): R1–R10. https://doi.org/10.1530/ERP-19-0049; Leon M.B., Smith C.R., Mack M. et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N. Engl. J. Med. 2010; 363: 1597–1607. https://doi.org/10.1056/NEJMoa1008232; Smith C.R., Leon M.B., Mack M.J. et al. Transcatheter versus surgical aortic- valve replacement in high-risk patients. N. Engl. J. Med. 2011; 364: 2187–2198. https://doi.org/10.1056/NEJMoa1103510; Blanke P., Weir-McCall J.R., Achenbach S. et al. Computed Tomography Imaging in the Context of Transcatheter Aortic Valve Implantation (TAVI)/Transcatheter Aortic Valve Replacement (TAVR): An Expert Con- sensus Document of the Society of Cardiovascular Computed Tomography. JACC Cardiovasc Imaging. 2019; 12: 1–24. https://doi.org/10.1016/j.jcmg.2018.12.003; Малахова М.В., Прохорова Е.А., Куличкин А.С., Бриль К.Р., Ван Е.Ю., Дзеранова А.Н., Галян Т.Н., Ховрин В.В., Чарчян Э.Р. Диагностика отрыва клапаносодержащего кондуита восходящего отдела аорты и его успешное хирургическое лечение. Вестник рентгенологии и радиологии. 2021; 102 (6): 383–389. https://doi.org/10.20862/0042-4676-2021-102-6-383-389; Контроль эффективных доз облучения пациентов при проведении медицинских рентгенологических исследований. Методические указания МУ 2.6.1.2944–11: 74–100.; Solbak M.S., Henning M.K., England A. et al. Impact of iodine concentration and scan parameters on image quality, contrast enhancement and radiation dose in thoracic CT. Eur. Radiol. Exp. 2020; 4 (1): 57. https://doi.org/10.1186/s41747-020-00184-z; Ghekiere O., Salgado R., Buls N. et al. Image quality in coronary CT angiography: challenges and technical solutions. Br. J. Radiol. 2017; 90 (1072): 20160567. https://doi.org/10.1259/bjr.20160567; Кондратьев Е.В., Кармазановский Г.Г. МСКТ-ангиография: Оптимизированные протоколы исследования коронарных артерий, сердца, аорты, сосудов шеи и головного мозга. М.: ВИДАР, 2011. 88 с.; Кондратьев Е.В., Кармазановский Г.Г., Широков В.С., Вишневская А.В., Швец Е.В. Низкодозовая КТангиография аорты и периферических артерий: эффек ты алгоритма итеративной реконструкции на качество получаемых изображений. Медицинская визуализация. 2013; 5: 11–22.; Shnayien S., Bressem K.K., Beetz N.L. et al. Radiation Dose Reduction in Preprocedural CT Imaging for TAVI/ TAVR Using a Novel 3-Phase Protocol: A Single Institution's Experience. Rofo. 2020; 192 (12): 1174–1182. http://doi.org/10.1055/a-1150-7646; Talei Franzesi C.R., Ippolito D., Riva L. et al. Diagnostic value of iterative reconstruction algorithm in low kV CT angiography (CTA) with low contrast medium volume for transcatheter aortic valve implantation (TAVI) planning: image quality and radiation dose exposure. Br. J. Radiol. 2018; 91 (1092): 20170802. http://doi.org/10.1259/bjr.20170802; Francone M., Budde R.P.J., Bremerich J. et al. CT and MR imaging prior to transcatheter aortic valve implantation: standardisation of scanning protocols, measurements and reporting-a consensus document by the European Society of Cardiovascular Radiology (ESCR). Eur. Radiol. 2019. http://doi.org/10.1007/s00330-019-06357-8; Meyer M., Haubenreisser H., Schoepf U.J. et al. Closing in on the K edge: coronary CT angiography at 100, 80, and 70 kV-initial comparison of a second- versus a thirdgeneration dual-source CT system. Radiology. 2014; 273 (2): 373–382. http://doi.org/10.1148/radiol.14140244; https://medvis.vidar.ru/jour/article/view/1149

  7. 7
    Academic Journal

    المصدر: The Siberian Journal of Clinical and Experimental Medicine; Том 37, № 2 (2022); 84-91 ; Сибирский журнал клинической и экспериментальной медицины; Том 37, № 2 (2022); 84-91 ; 2713-265X ; 2713-2927

    وصف الملف: application/pdf

    Relation: https://cardiotomsk.elpub.ru/jour/article/view/1423/713; Moon A.M., Singal A.G., Tapper E.B. Contemporary epidemiology of chronic liver disease and Cirrhosis. Clin. Gastroenterol. Hepatol. 2020;18(12):2650–2666. DOI:10.1016/j.cgh.2019.07.060.; Шимановский Н.Л. Оценка морфологических изменений и функции гепатобилиарной системы функции гепатобилиарной системы с помощью гадоксетовой кислоты (Примовиста). Анналы хирургической гепатологии. 2014;19(2):42–48.; Шориков М.А., Сергеева О.Н., Кашкадаева А.В., Аверинова С.Г., Лаптева М.Г., Францев Д.Ю. и др. Функциональная оценка печени у пациентов с заболеваниями желчных протоков с помощью гадоксетовой кислоты по сравнению с «золотым стандартом» – гепатобилисцинтиграфией. Вестник рентгенологии и радиологии. 2019;100(4):200–208. DOI:10.20862/0042-4676-2019-100-4-200-208.; Verloh N., Haimerl M., Zeman F., Schlabeck M., Barreiros A., Loss M. et al. Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla. Eur. Radiol. 2014;24(5):1013–1019. DOI:10.1007/s00330-014-3108-y.; Kim H., Park S.H., Kim E.K., Kim M.J., Park Y.N., Park H.J. et al. Histogram analysis of gadoxetic acid-enhanced MRI for quantitative hepatic fibrosis measurement. PLoS One. 2014;9(12):e114224. DOI:10.1371/journal.pone.0114224.; Арутюнянц Д.Э., Ховрин В.В., Галян Т.Н., Куличкин А.С., Тарба Н.С., Филин А.В. и др. Определение функции печени с помощью магнитно-резонансной томографии. Современная объективная реальность. Хирургия. Журнал им. Н.И. Пирогова. 2021;(6-2):89–94. DOI:10.17116/hirurgia202106289.; Ba-Ssalamah A., Bastati N., Wibmer A., Fragner R., Hodge J., Trauner M. et al. Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we? J. Magn. Reson. Imaging. 2017;45(3):646–659. 1. DOI:10.1002/jmri.25518.; Verloh N., Utpatel K., Haimerl M., Zeman F., Fellner C., Fichtner-Feig S. et al. Liver fibrosis and Gd-EOB-DTPA-enhanced MRI: A histopathologic correlation. Sci. Rep. 2015;5:15408. DOI:10.1038/srep15408.; Fujita N., Nishie A., Asayama Y., Ishigami K., Nakayama T., Ushijima Y. et al. Increased and more heterogeneous gadoxetic acid uptake of the liver parenchyma after epatitis C virus eradication by direct antiviral A. Magn. Reson. Med. Sci. 2020;19(4):389–393. DOI:10.2463/mrms.tn.2019-0183.; Asayama Y., Nishie A., Ishigami K., Ushijima Y., Takayama Y., Okamoto D. et al. Histogram analysis of noncancerous liver parenchyma on gadoxetic acid-enhanced MRI: Predictive value for liver function and pathology. Abdom. Radiol (NY). 2016;41(9):1751–1757. DOI:10.1007/s00261-016-0753-4.; Wibmer A., Prusa A.M., Nolz R., Gruenberger T., Schindl M., BaSsalamah A. Liver failure after major liver resection: Risk assessment by using preoperative gadoxetic acid-enhanced 3-T MR. Imag. Radiol. 2013;269(3):777–786. DOI:10.1148/radiol.13130210.; Asenbaum U., Kaczirek K., Ba-Ssalamah A., Ringl H., Schwarz C., Waneck F. et al. Post-hepatectomy liver failure after major hepatic surgery: Not only size matters. Eur. Radiol. 2018;28(11):4748–4756. DOI:10.1007/s00330-018-5487-y.; Poetter-Lang S., Bastati N., Messner A., Kristic A., Herold A., Hodge J.C. et al. Quantification of liver function using gadoxetic acid-enhanced MRI. Abdom. Radiol (NY). 2020;45(11):3532–3544. DOI:10.1007/s00261-020-02779-x.; Yamada A., Hara T., Li F., Fujinaga Y., Ueda K., Kadoya M. et al. Quantitative evaluation of liver function with use of gadoxetate disodium–enhanced MR imaging. Radiology. 2011;260(3):727–733. DOI:10.1148/radiol.11100586.; Kim D.K., Choi J.I., Choi M.H., Park M.Y., Lee Y.J., Rha S.E. et al. Prediction of posthepatectomy liver failure: MRI with hepatocyte-specific contrast agent versus indocyanine green clearance test. AJR. Am. J. Roentgenol. 2018;211(3):580–587. DOI:10.2214/AJR.17.19206.; https://cardiotomsk.elpub.ru/jour/article/view/1423

  8. 8
  9. 9
    Academic Journal

    المصدر: Russian Journal of Pediatric Hematology and Oncology; Том 6, № 3 (2019); 94-102 ; Российский журнал детской гематологии и онкологии (РЖДГиО); Том 6, № 3 (2019); 94-102 ; 2413-5496 ; 2311-1267 ; 10.21682/2311-1267-2019-6-3

    وصف الملف: application/pdf

    Relation: https://journal.nodgo.org/jour/article/view/534/500; Maris J.M. Recent advances in neuroblastoma. N Engl J Med 2010;362(23):2202–11. doi:10.1056/NEJMra0804577.; Goodman M.S., Gurney J.G., Smith M.A., Olshan A.F. Sympathetic nervous system tumors. In: Ries L.A.G., Smith M.A., Gurney J.G., Linet M., Tamra T., Young J.L. Jr, Bunin G.R., eds. Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995. National Cancer Institute, SEER Program. Bethesda, MD, 1999. Pp. 65–72.; Spix C., Pastore G., Sankila R., Stiller C.A., Steliarova-Foucher E. Neuroblastoma incidence and survival in European children (1978–1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006;42(13):2081–91. doi:10.1016/j.ejca.2006.05.008.; Matthay K.K., Maris J.M., Schleiermacher G., Nakagawara A., Mackall C.L., Diller L., Weiss W.A. Neuroblastoma. Nat Rev Dis Primers 2016;2:16078. doi:10.1038/nrdp.2016.78.; Matthay K.K., Villablanca J.G., Seeger R.C., Stram D.O., Harris R.E., Ramsay N.K., Swift P., Shimada H., Black C.T., Brodeur G.M., Gerbing R.B., Reynolds C.P. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. N Engl J Med 1999;341:1165–73. doi:10.1056/NEJM199910143411601.; Laino M.E., Monti S., Klimstra D.S., Tang L.H., Mannelli L. Treatment-related Focal Nodular Hyperplasia Mimicking Liver Metastases. J Pediatr Hematol Oncol 2019;41(2):138–9. doi:10.1097/ MPH.0000000000001362.; Bouyn C.I., Leclere J., Raimondo G., Le Pointe H.D., Couanet D., Valteau-Couanet D., Hartmann O. Hepatic focal nodular hyperplasia in children previously treated for a solid tumor. Incidence, risk factors, and outcome. Cancer 2003;97:3107–13. doi: 10,1002/cncr.11452.; Kumagai H., Masuda T., Oikawa H., Endo K., Takano T. Focal nodular hyperplasia of the liver: direct evidence of circulatory disturbances. J Gastroenterol Hepatol 2000;15:1344–7. PMID: 11129233.; International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 1995;22:983–93. PMID: 7657307.; Franchi-Abella S., Branchereau S. Benign hepatocellular tumors in children: focal nodular hyperplasia and hepatocellular adenoma. Int J Hepatol 2013; 2013:215064. doi:10.1155/2013/215064.; Stocker J.T., Kamal G.I. Focal nodular hyperplasia of the liver: a study of 21 pediatric cases Cancer 1981;48(2):336–45. PMID: 7237404.; Pillon M., Carucci N.S., Mainardi C., Carraro E., Zuliani M., Chemello L., Calore E., Tumino M., Varotto S., Toffolutti T., Destro R., Gazzola M. V., Alaggio R., Basso G., Messina C. Focal nodular hyperplasia of the liver: an emerging complication of hematopoietic SCT in children. Bone Marrow Transplant 2015;50(3):414–9. doi:10.1038/bmt.2014.276.; Joyner B.L., Goyal R.K., Newman B., Levin T.L. Focal nodular hyperplasia of the liver: a sequela of tumor therapy. Pediatr Radiol 2005;35(12):1234–9. doi:10.1007/s00247-005-1558-8.; Fan C.Q., Crawford J.M. Sinusoidal obstruction syndrome (hepatic veno-occlusive disease). J Clin Exp Hepatol 2014;4(4):332–46. doi:10.1016/j.jceh.2014.10.002.; Masetti R., Colecchia A., Rondelli R., Martoni A., Vendemini F., Biagi C., Prete A., Festi D., Lima M., Pession A. Benign hepatic nodular lesions after treatment for childhood cancer. J Pediatr Gastroenterol Nutr 2013;56(2):151–5. doi:10.1097/MPG.0b013e31826f7660.; Berthold F., Ernst A., Hero B., Klingebiel T., Kremens B., Schilling F. H., Simon T. Long-term outcomes of the GPOH NB97 trial for children with high-risk neuroblastoma comparing high-dose chemotherapy with autologous stem cell transplantation and oral chemotherapy as consolidation. Br J Cancer 2018;119(3):282–90. doi:10.1038/s41416-018-0169-8.; Elzembely M.M., Dahlberg A.E., Pinto N., Leger K.J., Chow E.J., Park J.R., Carpenter P.A., Baker K.S. Late effects in high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell rescue. Pediatr Blood Cancer 2019;66(1):e27421. doi:10.1002/pbc.27421.; Benz-Bohm G., Hero B., Gossmann A., Simon T., Körber F., Berthold F. Focal nodular hyperplasia of the liver in longterm survivors of neuroblastoma: how much diagnostic imaging is necessary? Eur J Radiol 2010;74(3):e1–5. doi:10.1016/j.ejrad.2009.03.011.; Bartolotta T.V., Midiri M., Scialpi M., Sciarrino E., Galia M., Lagalla R. Focal nodular hyperplasia in normal and fatty liver: a qualitative and quantitative evaluation with contrast-enhanced ultrasound. Eur Radiol 2004;14:583–91. doi:10.1007/s00330-003-2089-z.; Wang W., Chen L.D., Lu M.D., Liu G.J., Shen S.L., Xu Z.F., Xie X.Y., Wang Y., Zhou L.Y. Contrast-enchanced ultrasound features of histologically proven focal nodular hyperplasia: diagnostic performance compared with contrast-encanced CT. Eur Radiol 2013;23(9):2546–54. doi:10.1007/s00330-013-2849-3.; Dill-Macky M.J., Burns P.N., Khalili K., Wilson S.R. Focal hepatic masses: enhancement patterns with SH U 508A and pulse-inversion US. Radiology 2002;222: 1:95–102. doi:10.1148/radiol.2221010092.; Lencioni R., Cioni D., Bartolozzi C. Focal liver lesions, detection, characterization, ablation. Springer Verlag, 2005. ISBN: 3540644644.; Li A.-J., Zhou W.P., Wu M.C. Diagnosis and treatment of hepatic focal nodular hyperplasia: report of 114 cases. Zhonghua Wai Ke Za Zhi (Chinese J Surg) 2006;44(5):321–3. PMID: 16635391.; Mortele K.J., Praet M., Van Vlierberghe H., Kunnen M., Ros P.R. CT and MR imaging findings in focal nodular hyperplasia of the liver: radiologic-pathologic correlation. Am J Roentgenol 2000;175(3):687–92. doi:10.2214/ajr.175.3.1750687.; Seale M.K., Catalano O.A., Saini S., Hahn P.F., Sahani D.V. Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics: a review publication of the Radiological Society of North America 2009;29(6):1725–48. doi:10.1148/rg.296095515.; Sharp S.E., Trout A.T., Weiss B.D., Gelfand M.J. MIBG in Neuroblastoma Diagnostic Imaging and Therapy. Radiographics 2016;36(1):258–78. doi:10.1148/rg.2016150099.; Vik T.A., Pfluger T., Kadota R., Castel V., Tulchinsky M., Farto J.C., Heiba S., Serafini A., Tumeh S., Khutoryansky N., Jacobson A.F. (123) I-mIBG scintigraphy in patients with known or suspected neuroblastoma: Results from a prospective multicenter trial. Pediatr Blood Cancer 2009;52(7):784–90. doi:10.1002/pbc.21932.; Nakajo M., Shapiro B., Copp J., Kalff V., Gross M.D., Sisson J.C., Beierwaltes W.H. The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131] iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy. J Nucl Med 1983;24(8):672–82. PMID: 6135764.; Jacobsson H., Hellström P.M., Kogner P., Larsson S.A. Different concentrations of I-123 MIBG and In-111 pentetreotide in the two main liver lobes in children: persisting regional functional differences after birth? Clin Nucl Med 2007;32(1):24–8. doi:10.1097/01.rlu.0000249592.95945.e4.; Kulatunge C.R., Son H. False-positive 123I-MIBG scintigraphy due to multiple focal nodular hyperplasia. Clin Nucl Med 2013;38(12):976–8. doi:10.1097 / RLU.0000000000000234.; https://journal.nodgo.org/jour/article/view/534

  10. 10
    Academic Journal

    المصدر: Russian Journal of Pediatric Hematology and Oncology; Том 2, № 4 (2015); 108-110 ; Российский журнал детской гематологии и онкологии (РЖДГиО); Том 2, № 4 (2015); 108-110 ; 2413-5496 ; 2311-1267 ; 10.17650/2311-1267-2015-2-4

    وصف الملف: application/pdf

    Relation: https://journal.nodgo.org/jour/article/view/168/163; Aldrighetti L., Cetta F., Ferla G. Benign Tumors of the Liver. Springer International Publishing, 2015.; Chung E.B. Multiple bile-duct hamartomas. Cancer 1970;26(2):287–96.; Thommesen N. Biliary hamartomas (von Meyenburg complexes) in liver needle biopsies. Acta Pathol Microbiol Scand A 1978;86(2):93–9.; von Meyenburg H. Über die Zyztenleber. Beiträge zur pathologischen Anatomie und zur allgemeinen Pathologie. Jena 1918;64:477–532.; Song J.S., Noh S.J., Cho B.H., Moon W.S. Multicystic biliary hamartoma of the liver. Korean J Pathol 2013;47(3):275–8.; Ioannidis O., Iordanidis F., Paraskevas G. et al. Incidentally discovered white subcupsular liver nodules during laparoscopic surgery: biliary hamartoma and peribiliary gland hamartoma. Klin Onkol 2012;25(6):468–70.; Gil-Bello D., Ballesteros E., Sanfeliu E., Andreu F.J. Calcification in biliary hamartomatosis. Br J Radiol 2012;85(1012):e99–101.; Tröltzsch M., Borte G., Kahn T. et al. Non-invasive diagnosis of von Meyenburg complexes. J Hepatol 2003;39(1):129.; Horton K.M., Bluemke D.A., Hruban R.H. et al. CT and MR imaging of benign hepatic and biliary tumors. Radiographics 1999;19(2):431–51.; Makhneva A., Bekisheva A., Bulegenova M., Adamova G. Child's von meyenburg complexes. J Histol Histopathol 2015;2(15):1–3.; Cholangiocarcinoma arising from preexisting biliary hamartoma of liver – report of a case. Hepatogastroenterology 2003;50(50):333–6.; https://journal.nodgo.org/jour/article/view/168

  11. 11
    Academic Journal

    المصدر: Russian Journal of Pediatric Hematology and Oncology; Том 2, № 3 (2015); 58-60 ; Российский журнал детской гематологии и онкологии (РЖДГиО); Том 2, № 3 (2015); 58-60 ; 2413-5496 ; 2311-1267 ; 10.17650/2311-1267-2015-2-3

    وصف الملف: application/pdf

    Relation: https://journal.nodgo.org/jour/article/view/127/123; McDonald G.B. Hepatobiliary complications of hematopoietic cell transplant, 40 years on. Hepatology 2010;51(4):1450–60.; Tuncer H.H., Rana N., Milani C. et al. Gastrointestinal and hepatic complications of hematopoietic stem cell transplantation. World J Gastroenterol 2012;18(16):1851–60.; Fan C.Q., Crawford J.M. Sinusoidal obstruction syndrome (hepatic venoocclusive disease). J Clin Exp Hepatol 2014;4(4):332–46.; Norvell J.P. Liver disease after hematopoietic cell transplantation in adults. Transplant Rev (Orlando) 2015;29(1):8–15.; Landfried K., Wolff D., Holler E. Pathophysiology and management of graftversus- host disease in the era of of reducedintensity conditioning. Curr Opin Oncol 2009;21 Suppl 1:S39–41.; Garnett C., Apperley J.F., Pavlů J. Treatment and management of graft-versushost disease: improving response and survival. Ther Adv Hematol 2013;4(6):366–78.; Shimizu T., Kasahara M., Tanaka K. Living-donor liver transplantation for chronic hepatic raft-versushost disease.N Engl J Med 2006;354(14):1536–7.; Barshes N.R., Myers G.D., Lee D. et al. Liver transplantation for severe hepatic graftversus- host disease: an analysis of aggregate survival data. Liver Transpl 2005;11(5):525–31.; Hashmi S., Taner T., Patnaik M. et al. Liver Transplantation for Hepatic Graft- Versus-Host-Disease: A United Network for Organ Sharing (UNOS) Database Study. Biol Blood Marrow Transplant 2015;21(2):S331; https://journal.nodgo.org/jour/article/view/127

  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17